Investing Profile
Richard Heyman
InvestorVC
Venture Partner at ARCH Venture Partners
archventure.com/team/richard-...Encinitas, California
Your Intro Paths to Richard Heyman
Find Richard Heyman on
cbCurrent Investing Position
ARCH Venture Partners Venture Partner
Investment Range
$50K - $150.0M
Sweet Spot
$25.0M
Current Fund Size
$635.8M
Richard Heyman is on these Sector & Stage Rankings
Richard Heyman's Experience
Chairperson of the Board RayzeBio2022 - Present
Board of Director and Scientific Advisory Board Member Curebound2021 - Present
BOD Member/Chairman Enliven Therapeutics2020 - Present
Board of Managers Life Science Cares San Diego2020 - Present
Chairman of the Board PMV Pharmaceuticals, Inc.2020 - Present
Venture Partner ARCH Venture Partners2020 - Present
Chairman/BOD member Vividion Therapeutics, Inc.2018 - Present
Vice Chairman of The Board of Trustees Salk Institute for Biological Studies2015 - Present
Chairman of the BOD Aragon Pharmaceuticals2014 - Present
Executive Chairman Metacrine Inc.2015 - 2022
Chairperson of the Board Amunix Pharmaceuticals2019 - 2021
BOD Member Yumanity Therapeutics2016 - 2021
BOD Member Gritstone Oncology2015 - 2021
President and CEO Seragon Pharmaceuticals2013 - 2015
President and CEO Aragon Pharmaceuticals2009 - 2013
Chief Scientific Officer Kalypsys, Inc.2006 - 2008
Sr. Vice President Exelixis, Inc.2004 - 2006
CSO X-Ceptor Therapeutics1999 - 2006
VP Research Ligand Pharmaceuticals1990 - 1999
Postdoctoral Fellow Salk Institute1986 - 1990
Richard Heyman's Education
University of Minnesota PhD Pharmacology
Investors who invest with Richard Heyman
Founders who looked at Richard Heyman's profile also looked at these Scouts & Angels